Home › Funds › AVENIR CORP › CTSO

AVENIR CORP position in CTSO

CYTOSORBENTS CORP · Health Care

AVENIR CORP reported holding 259,092 shares of CTSO (CYTOSORBENTS CORP) in its Q3 2026 13F filing — a position valued at US$1.0M, representing 0.12% of its reported portfolio and ranking #39 among its reported holdings. AVENIR CORP has disclosed CTSO holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)259.09K sh
Reported value held$1.01M
Portfolio Weight0.12%
First reportedQ3 2023
Last changeReduce
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How AVENIR CORP's CTSO position evolved

AVENIR CORP first disclosed a stake in CTSO in Q3 2023 at 2,717,397 shares (US$5.1M). The position peaked in Q2 2025 at 5,058,537 shares, worth US$6.5M. Across 13 filings, AVENIR CORP increased the stake 5 time(s), trimmed it 3 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 259,092 shares valued at US$1.0M — a reduction of -4,930,126 shares quarter over quarter.. Notable position changes include a 63% increase in Q1 2025 (shares rose 28% over the following quarter), a 95% trim in Q3 2026 (shares rose 25% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 2.72M $5.11M New
Q4 2023 3.05M $3.39M Add
Q1 2024 3.17M $3.01M Add
Q2 2024 2.97M $2.09M Reduce
Q3 2024 2.98M $4.46M Hold
Q4 2024 3.09M $2.82M Add
Q1 2025 5.04M $5.04M Add
Q2 2025 5.06M $6.47M Hold
Q3 2025 5.08M $4.75M Hold
Q4 2025 5.23M $3.34M Add
Q1 2026 5.22M $2.95M Hold
Q2 2026 5.19M $1.94M Reduce
Q3 2026 259.09K $1.01M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CTSO and 13F data

CTSO (CYTOSORBENTS CORP) is a Health Care company. 10 other funds we track also report a position in CTSO. Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CTSO

No other tracked fund reports a position in CTSO.

All CTSO fund holders →

FAQ

How long has AVENIR CORP held CTSO?

AVENIR CORP has disclosed CTSO holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is AVENIR CORP's current position in CTSO?

As of Q3 2026, AVENIR CORP holds 259.09K shares of CTSO (CYTOSORBENTS CORP), valued at $1.01M, representing 0.12% of its reported portfolio and ranking #39.

Has AVENIR CORP been buying or selling CTSO?

In the latest 13F filing (Q3 2026), AVENIR CORP reduced its position in CTSO. The position peaked in Q2 2025 at 5.06M shares.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.